Drones have always been flying robots, but all those smarts haven't stopped them from flying backwards into trees, walls and people. The new DJI Phantom 4 Pro won't do that. This is DJI's first drone ...
I often draw comparisons between DJI and Apple. Though one makes phones and tablets and the other drones, they each have reached a design plateau in their respective categories and the updates they ...
The DJI Osmo Pocket 4 Pro may finally be close to launch, and a newly surfaced image is giving us the clearest look yet at what sets it apart. The photo, which shows the device from the front, appears ...
A leaked image of the DJI Osmo Pocket 4 Pro has surfaced online, confirming widespread speculation that the upcoming device will feature a dual camera setup. The photo, reportedly taken at an indoor ...
DJI’s next pocket-sized vlogging camera might have just revealed itself in the way too many gadgets get leaked these days - via someone “accidentally” snapping a photo of it in public. A new image ...
The latest leak suggests DJI’s next compact gimbal camera could be just around the corner. Retail packaging believed to belong to the DJI Osmo Pocket 4 has surfaced online, offering an early look at ...
Modern drones have significantly improved long-range capabilities and safety features, offering a much more reliable connection than earlier models. While drones are technically capable of flying long ...
The F-4 Phantom II was one of the most iconic fighter jets of the Cold War — loud, fast, and brutal. This project takes a real Phantom that had been sitting dormant for years and restores it piece by ...
Did our AI summary help? The Nifty 50 on February 3 recorded the biggest single-day rally of 2.5 percent in nearly nine months after the India–US trade deal removed a major sentiment overhang that had ...
Meta Platforms (META) remains a 'Strong buy' ahead of Q4 2025 earnings, with a compelling valuation and robust business fundamentals. META's core digital advertising business drives expanding gross ...
Novo Nordisk A/S's restructuring costs are front-loaded in Q3, with DKK 1 billion in savings accruing to Q4 earnings, setting up a potential beat on low expectations. The FDA-approved Wegovy oral pill ...